摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(1-吖丁啶基)哌啶二盐酸盐 | 864246-02-6

中文名称
4-(1-吖丁啶基)哌啶二盐酸盐
中文别名
4-(1-吖啶基)哌啶二盐酸盐
英文名称
4-(Azetidin-1-yl)piperidine dihydrochloride
英文别名
4-(azetidin-1-yl)piperidine;dihydrochloride
4-(1-吖丁啶基)哌啶二盐酸盐化学式
CAS
864246-02-6
化学式
C8H18Cl2N2
mdl
——
分子量
213.15
InChiKey
MOTOMPUZVPDAQF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.29
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    15.3
  • 氢给体数:
    3
  • 氢受体数:
    2

安全信息

  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335

反应信息

  • 作为反应物:
    描述:
    [4-(2-fluoro-4-{[1-(4-fluorophenylcarbamoyl)cyclopropanecarbonyl]amino}phenoxy)pyridin-2-yl]-N-(phenoxycarbonyl)carbamic acid phenyl ester4-(1-吖丁啶基)哌啶二盐酸盐三乙胺乙酸乙酯氯化铵 、 Brine 、 Sodium sulfate-III 、 resultant residue 、 silica gel 、 乙醚 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 24.0h, 以to provide the titled compound as white powder (34.6 mg, 59%)的产率得到N-{4-[(2-{[(4-azetidin-1-ylpiperidin-1-yl)carbonyl]amino}pyridin-4-yl)oxy]-3-fluorophenyl}-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
    参考文献:
    名称:
    Pyridine derivatives and pyrimidine derivatives (3)
    摘要:
    以下化合物的公式,其盐或其水合物具有出色的肝细胞生长因子受体(HGFR)抑制活性,并表现出抗肿瘤活性、抑制血管生成活性和癌症转移抑制活性。[R1代表3-至10-成员非芳香杂环基团或类似物;R2和R3代表氢;R4、R5、R6和R7可以相同也可以不同,每个代表氢、卤素、C1-6烷基或类似物;R8代表氢或类似物;R9代表3-至10-成员非芳香杂环基团或类似物;n表示1或2;X表示-CH═、氮或类似物。]
    公开号:
    US07855290B2
  • 作为产物:
    描述:
    4-(Azetidin-1-yl)-1-benzylpiperidine dihydrochloride 、 在 palladium-carbon 氢气异丙醇乙醇正己烷 作用下, 以 异丙醇 为溶剂, 反应 23.0h, 以to provide the title compound (4.26 g) as white powder的产率得到4-(1-吖丁啶基)哌啶二盐酸盐
    参考文献:
    名称:
    Novel pyridine derivative and pyrimidine derivative
    摘要:
    以下化合物、其盐或水合物,具有优异的肝细胞生长因子受体(HGFR)抑制活性,并表现出抗肿瘤活性、抑制血管生成活性和癌症转移抑制活性。[其中R1代表C1-6烷基或类似物;R2和R3代表氢;R4、R5、R6和R7可以相同也可以不同,每个代表氢、卤素、C1-6烷基或类似物;R8代表氢或类似物;R9代表C1-6烷基或类似物;V1代表氧或类似物;V2代表氧或硫;W代表—NH—或类似物;X代表—CH═、氮或类似物;Y代表氧或类似物。]
    公开号:
    US20050277652A1
点击查看最新优质反应信息

文献信息

  • NOVEL THIENOPYRROLE COMPOUNDS
    申请人:Wishart Neil
    公开号:US20110152243A1
    公开(公告)日:2011-06-23
    The invention provides a compound of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
    该发明提供了公式(I)的化合物,包括药用盐、前药、生物活性代谢物、立体异构体和同分异构体,其中变量在此处定义。该发明的化合物可用于治疗免疫和肿瘤疾病。
  • Novel pyridine derivatives and pyrimidine derivatives (3)
    申请人:Matsushima Tomohiro
    公开号:US20080319188A1
    公开(公告)日:2008-12-25
    A compound represented by the following formula, a salt thereof or a hydrate of the foregoing has an excellent hepatocyte growth factor receptor (HGFR) inhibitory activity, and exhibits anti-tumor activity, angiogenesis inhibitory activity and cancer metastasis inhibitory activity. [R 1 represents a 3- to 10-membered non-aromatic heterocyclic group or the like; R 2 and R 3 represent hydrogen; R 4 , R 5 , R 6 , and R 7 may be the same or different and each represents hydrogen, halogen, C 1-6 alkyl or the like; R 8 represents hydrogen or the like; R 9 represents a 3- to 10-membered non-aromatic heterocyclic group or the like; n represents an integer of 1 or 2; X represents —CH═, nitrogen or the like.]
    以下化合物,其盐或合物,具有优异的肝细胞生长因子受体(HGFR)抑制活性,表现出抗肿瘤活性、抑制血管生成活性和癌症转移抑制活性。[其中,R1代表3-至10-成员的非芳香族杂环基团等;R2和R3代表氢;R4、R5、R6和R7可以相同或不同,每个代表氢、卤素、C1-6烷基或类似物;R8代表氢或类似物;R9代表3-至10-成员的非芳香族杂环基团等;n代表1或2的整数;X代表-CH═,氮或类似物。]
  • Novel pyridine Derivative and Pyrimidine Derivative (1)
    申请人:Matsushima Tomohiro
    公开号:US20070270421A1
    公开(公告)日:2007-11-22
    A compound represented by the following formula, a salt thereof or a hydrate of the foregoing has an excellent hepatocyte growth factor receptor (HGFR) inhibitory activity, and exhibits anti-tumor activity, angiogenesis inhibitory activity and cancer metastasis inhibitory activity. [R 1 represents C 1-6 alkyl or the like; R 2 and R 3 represent hydrogen; R 4 , R 5 , R 6 , and R 7 may be the same or different and each represents hydrogen, halogen, C 1-6 alkyl or the like; R 8 represents hydrogen or the like; R 9 represents C 1-6 alkyl or the like; V 1 represents oxygen or the like; V 2 represents oxygen or sulfur; W represents —NH— or the like; X represents —CH═, nitrogen or the like; and Y represents oxygen or the like.]
    以下化合物的公式,其盐或合物具有出色的肝细胞生长因子受体(HGFR)抑制活性,并表现出抗肿瘤活性,抑制血管生成活性和癌症转移抑制活性。 [其中,R1代表C1-6烷基或类似物; R2和R3代表氢; R4,R5,R6和R7可能相同或不同,每个代表氢,卤素,C1-6烷基或类似物; R8代表氢或类似物; R9代表C1-6烷基或类似物; V1代表氧或类似物; V2代表氧或; W代表—NH—或类似物; X代表—CH═、氮或类似物; Y代表氧或类似物。]
  • NOVEL PYRIDINE DERIVATIVES AND PYRIMIDINE DERIVATIVES (3)
    申请人:MATSUSHIMA Tomohiro
    公开号:US20100075944A1
    公开(公告)日:2010-03-25
    A compound represented by the following formula, or a salt thereof or a hydrate of the foregoing, has excellent hepatocyte growth factor receptor (HGFR) inhibitory activity, and exhibits anti-tumor activity, angiogenesis inhibitory activity, and cancer metastasis inhibitory activity. R 1 represents a 3- to 10-membered non-aromatic heterocyclic group or the like; R 2 and R 3 represent hydrogen; R 4 , R 5 , R 6 , and R 7 may be the same or different and each represents hydrogen, halogen, C 1-6 alkyl or the like; R 8 represents hydrogen or the like; R 9 represents a 3- to 10-membered non-aromatic heterocyclic group or the like; n represents an integer of 1 or 2; X represents —CH═, nitrogen or the like.
    以下化合物的分子式,或其盐或合物,具有出色的肝细胞生长因子受体(HGFR)抑制活性,并表现出抗肿瘤活性、抑制血管生成活性和癌症转移抑制活性。其中,R1代表3-10个成员的非芳香杂环基团等;R2和R3代表氢;R4、R5、R6和R7可以相同也可以不同,每个代表氢、卤素、C1-6烷基或类似物;R8代表氢或类似物;R9代表3-10个成员的非芳香杂环基团等;n代表1或2的整数;X代表-CH═、氮或类似物。
  • Pyridine derivative and pyrimidine derivative
    申请人:Eisai R&D Management Co., Ltd.
    公开号:US07531532B2
    公开(公告)日:2009-05-12
    A compound represented by the following formula, a salt thereof or a hydrate of the foregoing has an excellent hepatocyte growth factor receptor (HGFR) inhibitory activity, and exhibits anti-tumor activity, angiogenesis inhibitory activity and cancer metastasis inhibitory activity. [R1 represents C1-6 alkyl or the like; R2 and R3 represent hydrogen; R4, R5, R6, and R7 may be the same or different and each represents hydrogen, halogen, C1-6 alkyl or the like; R8 represents hydrogen or the like; R9 represents C1-6 alkyl or the like; V1 represents oxygen or the like; V2 represents oxygen or sulfur; W represents —NH— or the like; X represents —CH═, nitrogen or the like; and Y represents oxygen or the like.]
    以下化合物的公式,其盐或合物具有出色的肝细胞生长因子受体(HGFR)抑制活性,并表现出抗肿瘤活性、抗血管生成活性和癌症转移抑制活性。【R1代表C1-6烷基或类似物;R2和R3代表氢;R4、R5、R6和R7可以相同也可以不同,每个代表氢、卤素、C1-6烷基或类似物;R8代表氢或类似物;R9代表C1-6烷基或类似物;V1代表氧或类似物;V2代表氧或;W代表—NH—或类似物;X代表—CH═、氮或类似物;Y代表氧或类似物。】
查看更多

同类化合物

(R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 ((3S,4R)-3-氨基-4-羟基哌啶-1-基)(2-(1-(环丙基甲基)-1H-吲哚-2-基)-7-甲氧基-1-甲基-1H-苯并[d]咪唑-5-基)甲酮盐酸盐 高氯酸哌啶 高托品酮肟 马来酸帕罗西汀 颜料红48:4 顺式3-氟哌啶-4-醇盐酸盐 顺式2,6-二甲基哌啶-4-酮 顺式1-苄基-4-甲基-3-甲氨基-哌啶 顺式-叔丁基4-羟基-3-甲基哌啶-1-羧酸酯 顺式-6-甲基-哌啶-1,3-二甲酸1-叔丁酯 顺式-5-(三氟甲基)哌啶-3-羧酸甲酯盐酸盐 顺式-4-叔丁基-2-甲基哌啶 顺式-4-Boc-氨基哌啶-3-甲酸甲酯 顺式-4-(氮杂环丁烷-1-基)-3-氟哌 顺式-3-顺式-4-氨基哌啶 顺式-3-甲氧基-4-氨基哌啶 顺式-3-BOC-3,7-二氮杂双环[4.2.0]辛烷 顺式-3-(1-吡咯烷基)环丁腈 顺式-3,5-哌啶二羧酸 顺式-3,4-二溴-3-甲基吡咯烷盐酸盐 顺式-2,6-二甲基-4-氧代哌啶-1-羧酸叔丁基酯 顺式-1-叔丁氧羰基-4-甲基氨基-3-羟基哌啶 顺式-1-boc-3,4-二氨基哌啶 顺式-1-(4-叔丁基环己基)-4-苯基-4-哌啶腈 顺式-1,3-二甲基-4-乙炔基-6-苯基-3,4-哌啶二醇 顺-4-(4-氟苯基)-1-(4-异丙基环己基)-4-哌啶羧酸 顺-4-(2-氟苯基)-1-(4-异丙基环己基)-4-哌啶羧酸 顺-3-氨基-4-氟哌啶-1-羧酸叔丁酯 顺-1-苄基-4-甲基哌啶-3-氨基酸甲酯盐酸盐 非莫西汀 雷芬那辛 雷拉地尔 阿维巴坦中间体4 阿格列汀杂质 阿尼利定盐酸盐 CII 阿尼利定 阿塔匹酮 阿哌沙班杂质BMS-591455 阿哌沙班杂质87 阿哌沙班杂质52 阿哌沙班杂质51 阿哌沙班杂质5 阿哌沙班杂质 阿哌沙班杂质 阿哌沙班-d3 阿哌沙班 阻聚剂701 间氨基谷氨酰胺